ArticleMicrobial biotechnology2025
Food for Thoughts for Prospective Biomanufacturing.
Article in Microbial biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Simulating large-scale biotech bubble columns: challenges and insights from the parcel approach.Bioprocess and biosystems engineering · 2026Article
- Biomanufacturing and Scale-Up: Pathways to Biochemicals, Biofuels, and Biomaterials.Microbial biotechnology · 2026Article
- Eco-Microbiology: A Frugal-Circular Framework for Biosafe, Low-Cost Practical Microbiology in Secondary Education.Microbial biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While rising greenhouse gases cause climate change, global economies ask for resilient solutions for the business of the future. Biomanufacturing may well serve as a pillar of a circular economy with minimised environmental impact. Therefore, innovations of the lab need to successfully bridge the imminent 'death-valley of innovation' for making commercial production happen. This editorial aims to prepare the ground for prospective developments so as to the seed of novel ideas will prosper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.